(1)
Elsamany, S. A.; Elemam, O.; Hassanin, F.; Algahami, A.; Alghanmi, H.; El naghi, K. A. E. A. Neoadjuvant Chemotherapy Plus Denosumab Compared to Chemotherapy Alone in Hormonal Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Premenopausal Breast Cancer Patients. World J Oncol 2025. https://doi.org/10.14740/wjon2546.